Before you sell to, join or invest in OncoNano Medicine, Inc.
MentionFox check on OncoNano Medicine, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/onconano-medicine-inc-form-d-25000001
Check OncoNano Medicine, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about OncoNano Medicine, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
OncoNano Medicine, Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-02.
OncoNano Medicine, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 2, 2025. The filing reports $12.70M sold. Its industry group is Biotechnology. It names Kartik Krishnan (Executive Officer, Director), Melissa Paoloni (Executive Officer), Matthew Head (Executive Officer) (SEC Form D, June 2, 2025).
Is this your company?
Sell to companies like OncoNano Medicine, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-02 · the record
Pitching, partnering or investing alongside them? See who really runs and owns OncoNano Medicine, Inc.
Free to see. No signup.
More on the people and the money behind OncoNano Medicine, Inc., from the filings we hold.
Biotechnology raises by companies based in Texas, filed within 90 days of this one, largest first.
Get an email when OncoNano Medicine, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when OncoNano Medicine, Inc. raises, hires or launches. No email unless you switch it on.
Watch OncoNano Medicine, Inc. →Get the full cited report on OncoNano Medicine, Inc.
What the filing shows about OncoNano Medicine, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on OncoNano Medicine, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives OncoNano Medicine, Inc.'s address as 3060 Pegasus Park Drive, Dallas, TX 75247.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for OncoNano Medicine, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on OncoNano Medicine, Inc. See pricing
OncoNano Medicine, Inc. is a registered filer with the SEC (CIK 1735726) and has filed since 2025-06-02. 2 filings are on record, the latest on 2026-10-08.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
OncoNano Medicine, Inc.'s Form D of 2025-06-02 names Kartik Krishnan, Melissa Paoloni, Matthew Head and 4 more as its officers, directors or promoters.
Its new offerings report $22.75M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Kartik Krishnan is named as Executive Officer and Director on the Form D that OncoNano Medicine, Inc. filed with the SEC on 2 June 2025, one of 7 people that filing names.
Melissa Paoloni is named as Executive Officer on the Form D that OncoNano Medicine, Inc. filed with the SEC on 2 June 2025, one of 7 people that filing names.
Matthew Head is named as Executive Officer on the Form D that OncoNano Medicine, Inc. filed with the SEC on 2 June 2025, one of 7 people that filing names.
Brett Giroir is named as Director on the Form D that OncoNano Medicine, Inc. filed with the SEC on 2 June 2025, one of 7 people that filing names.
John Dyett is named as Director on the Form D that OncoNano Medicine, Inc. filed with the SEC on 2 June 2025, one of 7 people that filing names.
Gina Jones is named as Director on the Form D that OncoNano Medicine, Inc. filed with the SEC on 2 June 2025, one of 7 people that filing names.
Yumin Qui is named as Director on the Form D that OncoNano Medicine, Inc. filed with the SEC on 2 June 2025, one of 7 people that filing names.
7 people named on the filing — 3 holding an executive role and 4 as directors only.
Named as of the 2025-06-02 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about OncoNano Medicine, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on OncoNano Medicine, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on OncoNano Medicine, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist OncoNano Medicine, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind OncoNano Medicine, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for OncoNano Medicine, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Dallas-Fort Worth
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/onconano-medicine-inc-form-d-25000001